{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:46:47Z","timestamp":1788058007333,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41390-021-01682-5","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T07:04:41Z","timestamp":1629788681000},"page":"1613-1620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies"],"prefix":"10.1038","volume":"92","author":[{"given":"Aryaz","family":"Sheybani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Raucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Burnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0009922809347777","volume":"49","author":"J Dooley","year":"2010","unstructured":"Dooley, J., Gordon, K. E., Dodds, L. & MacSween, J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin. Pediatr. (Philos) 49, 177\u2013179 (2010).","journal-title":"Clin. Pediatr. (Philos)"},{"key":"1682_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0887-8994(95)00251-0","volume":"14","author":"BJ Boland","year":"1996","unstructured":"Boland, B. J., Silbert, P. L., Groover, R. V., Wollan, P. C. & Silverstein, M. D. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr. Neurol. 14, 7\u201312 (1996).","journal-title":"Pediatr. Neurol."},{"key":"1682_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro, G., Comi, L. I., Politano, L. & Bain, R. J. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26, 271\u2013277 (1990).","journal-title":"Int. J. Cardiol."},{"key":"1682_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4187\/respcare.00831","volume":"56","author":"JR Bach","year":"2011","unstructured":"Bach, J. R. & Martinez, D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir. Care 56, 744\u2013750 (2011).","journal-title":"Respir. Care"},{"key":"1682_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ejpn.2016.07.020","volume":"20","author":"HJ Van Ruiten","year":"2016","unstructured":"Van Ruiten, H. J. et al. Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in North East England. Eur. J. Paediatr. Neurol. 20, 904\u2013909 (2016).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"1682_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00246-020-02309-y","volume":"41","author":"CA Wittlieb-Weber","year":"2020","unstructured":"Wittlieb-Weber, C. A. et al. Risk factors for cardiac and noncardiac causes of death in males with Duchenne muscular dystrophy. Pediatr. Cardiol. 41, 764\u2013771 (2020).","journal-title":"Pediatr. Cardiol."},{"key":"1682_CR7","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/ijms20174098","volume":"20","author":"TA Meyers","year":"2019","unstructured":"Meyers, T. A. & Townsend, D. Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy. Int. J. Mol. Sci. 20, 4098 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1682_CR8","doi-asserted-by":"publisher","first-page":"e000783","DOI":"10.1136\/openhrt-2018-000783","volume":"5","author":"M Wang","year":"2018","unstructured":"Wang, M., Birnkrant, D. J., Super, D. M., Jacobs, I. B. & Bahler, R. C. Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies. Open Heart 5, e000783 (2018).","journal-title":"Open Heart"},{"key":"1682_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0735-1097(00)01156-6","volume":"37","author":"Q Dao","year":"2001","unstructured":"Dao, Q. et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J. Am. Coll. Cardiol. 37, 379\u2013385 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1682_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","volume":"330","author":"JA Doust","year":"2005","unstructured":"Doust, J. A., Pietrzak, E., Dobson, A. & Glasziou, P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Br. Med. J. 330, 625 (2005).","journal-title":"Br. Med. J."},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.nmd.2004.08.002","volume":"14","author":"J Demachi","year":"2004","unstructured":"Demachi, J. et al. Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy. Neuromuscul. Disord. 14, 732\u2013739 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"1682_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/BF03086253","volume":"17","author":"EA van Bockel","year":"2009","unstructured":"van Bockel, E. A. et al. Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth. Heart J. 17, 232\u2013237 (2009).","journal-title":"Neth. Heart J."},{"key":"1682_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijcard.2006.07.163","volume":"119","author":"T Mohyuddin","year":"2007","unstructured":"Mohyuddin, T., Jacobs, I. B. & Bahler, R. C. B-type natriuretic peptide and cardiac dysfunction in Duchenne muscular dystrophy. Int. J. Cardiol. 119, 389\u2013391 (2007).","journal-title":"Int. J. Cardiol."},{"key":"1682_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00246-001-0040-0","volume":"23","author":"K Mori","year":"2002","unstructured":"Mori, K. et al. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne\u2019s progressive muscular dystrophy. Pediatr. Cardiol. 23, 160\u2013166 (2002).","journal-title":"Pediatr. Cardiol."},{"key":"1682_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.physiol.67.040403.114025","volume":"67","author":"T Kobayashi","year":"2005","unstructured":"Kobayashi, T. & Solaro, R. J. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu. Rev. Physiol. 67, 39\u201367 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"1682_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.109.893826","volume":"121","author":"JL Januzzi","year":"2010","unstructured":"Januzzi, J. L. et al. High-sensitivity Troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 121, 1227\u20131234 (2010).","journal-title":"Circulation"},{"key":"1682_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1017\/S1047951117001627","volume":"28","author":"SAE Saiedi","year":"2017","unstructured":"Saiedi, S. A. E. et al. Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a tissue Doppler imaging and Cardiac Troponin I Study. Cardiol. Young 28, 76\u201384 (2017).","journal-title":"Cardiol. Young"},{"key":"1682_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/0004563216650464","volume":"54","author":"M Jones","year":"2017","unstructured":"Jones, M., O\u2019Gorman, P., Kelly, C., Mahon, N. & Fitzgibbon, M. C. High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury. Ann. Clin. Biochem. 54, 149\u2013157 (2017).","journal-title":"Ann. Clin. Biochem."},{"key":"1682_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, C. et al. Predictive values of N-terminal Pro-B-type natriuretic peptide and cardiac Troponin I for myocardial fibrosis in hypertrophic obstructive cardiomyopathy. PLoS ONE 11 e0146572 (2016).","DOI":"10.1371\/journal.pone.0146572"},{"key":"1682_CR20","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/echo.13645","volume":"34","author":"A Agarwal","year":"2017","unstructured":"Agarwal, A. et al. Relationship of cardiac troponin to systolic global longitudinal strain in hypertrophic cardiomyopathy. Echocardiography 34, 1470\u20131477 (2017).","journal-title":"Echocardiography"},{"key":"1682_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","volume":"108","author":"TB Horwich","year":"2003","unstructured":"Horwich, T. B., Patel, J., Maclellan, W. R. & Fonarow, G. C. Cardiac Troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108, 833\u2013838 (2003).","journal-title":"Circulation"},{"key":"1682_CR22","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/clinchem\/41.12.1710","volume":"41","author":"GS Bodor","year":"1995","unstructured":"Bodor, G. S., Porterfield, D., Voss, E. M., Smith, S. & Apple, F. S. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin. Chem. 41, 1710\u20131715 (1995).","journal-title":"Clin. Chem."},{"key":"1682_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JND-170253","volume":"4","author":"KN Hor","year":"2017","unstructured":"Hor, K. N. et al. Progression of Duchenne cardiomyopathy presenting with chest pain and Troponin elevation. J. Neuromuscul. Dis. 4, 307\u2013314 (2017).","journal-title":"J. Neuromuscul. Dis."},{"key":"1682_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.braindev.2007.01.009","volume":"29","author":"T Matsumura","year":"2007","unstructured":"Matsumura, T., Saito, T., Fujimura, H. & Shinno, S. Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients. Brain Dev. 29, 496\u2013501 (2007).","journal-title":"Brain Dev."},{"key":"1682_CR25","doi-asserted-by":"crossref","unstructured":"Spurney, C. F. et al. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart (2021).","DOI":"10.1136\/openhrt-2021-001592"},{"key":"1682_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli, D. R. et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn. Reson. Med. 52, 141\u2013146 (2004).","journal-title":"Magn. Reson. Med."},{"key":"1682_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1532-429X-15-92","volume":"15","author":"JC Moon","year":"2013","unstructured":"Moon, J. C. et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J. Cardiovasc. Magn. Reson. 15, 92 (2013).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1682_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1532-429X-16-2","volume":"16","author":"P Kellman","year":"2014","unstructured":"Kellman, P. & Hansen, M. S. T1-mapping in the heart: accuracy and precision. J. Cardiovasc. Magn. Reson. 16, 2 (2014).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1682_CR29","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mrm.23153","volume":"67","author":"H Xue","year":"2012","unstructured":"Xue, H. et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn. Reson. Med. 67, 1644\u20131655 (2012).","journal-title":"Magn. Reson. Med."},{"key":"1682_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00246-014-0963-x","volume":"36","author":"JH Soslow","year":"2015","unstructured":"Soslow, J. H. et al. Evaluation of post-contrast myocardial t1 in Duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr. Cardiol. 36, 49\u201356 (2015).","journal-title":"Pediatr. Cardiol."},{"key":"1682_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCIMAGING.113.001472","volume":"7","author":"JA Dodson","year":"2014","unstructured":"Dodson, J. A. et al. Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation. Circ. Cardiovasc. Imaging 7, 586\u2013592 (2014 Jul).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1682_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira, M. D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105, 539\u2013542 (2002).","journal-title":"Circulation"},{"key":"1682_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cardfail.2019.02.006","volume":"25","author":"JH Soslow","year":"2019","unstructured":"Soslow, J. H. et al. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Duchenne muscular dystrophy cardiomyopathy. J. Card. Fail 25, 259\u2013267 (2019).","journal-title":"J. Card. Fail"},{"key":"1682_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli, D. R. et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn. Reson. Med. 52, 141\u2013146 (2004).","journal-title":"Magn. Reson. Med."},{"key":"1682_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377\u2013381 (2009).","journal-title":"J. Biomed. Inf."},{"key":"1682_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jacc.2010.06.016","volume":"56","author":"RD Kociol","year":"2010","unstructured":"Kociol, R. D. et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J. Am. Coll. Cardiol. 56, 1071\u20131078 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1682_CR37","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/eurheartj\/ehs191","volume":"33","author":"JL Januzzi Jr","year":"2012","unstructured":"Januzzi, J. L. Jr, Filippatos, G., Nieminen, M. & Gheorghiade, M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur. Heart J. 33, 2265\u20132271 (2012).","journal-title":"Eur. Heart J."},{"key":"1682_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00424-007-0354-8","volume":"455","author":"MH Hessel","year":"2008","unstructured":"Hessel, M. H. et al. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflug. Arch. 455, 979\u2013986 (2008).","journal-title":"Pflug. Arch."},{"key":"1682_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/hrt.2003.023895","volume":"90","author":"Y Sato","year":"2004","unstructured":"Sato, Y., Kita, T., Takatsu, Y. & Kimura, T. Biochemical markers of myocyte injury in heart failure. Heart 90, 1110\u20131113 (2004).","journal-title":"Heart"},{"key":"1682_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","volume":"335","author":"J Narula","year":"1996","unstructured":"Narula, J. et al. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335, 1182\u20131189 (1996).","journal-title":"N. Engl. J. Med"},{"key":"1682_CR41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1161\/01.CIR.102.11.1221","volume":"102","author":"R Labugger","year":"2000","unstructured":"Labugger, R. et al. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102, 1221\u20131226 (2000).","journal-title":"Circulation"},{"key":"1682_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ncpcardio1066","volume":"5","author":"AR Lyon","year":"2008","unstructured":"Lyon, A. R. et al. Stress (Takotsubo) cardiomyopathy\u2014a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat. Clin. Pract. Cardiovasc. Med. 5, 22\u201329 (2008).","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"1682_CR43","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","volume":"71","author":"J Schmid","year":"2018","unstructured":"Schmid, J. et al. Elevated cardiac troponin T in patients with skeletal myopathies. J. Am. Coll. Cardiol. 71, 1540\u20131549 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1682_CR44","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00246-020-02372-5","volume":"41","author":"S Voleti","year":"2020","unstructured":"Voleti, S. et al. Levels correlate with cardiac MR LGE and native T1 values in duchenne muscular dystrophy cardiomyopathy and identify early disease progression. Pediatr. Cardiol. 41, 1173\u20131179 (2020).","journal-title":"Pediatr. Cardiol."},{"key":"1682_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000336810","volume":"121","author":"SW Kwon","year":"2012","unstructured":"Kwon, S. W. et al. Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital. Cardiology 121, 186\u2013193 (2012).","journal-title":"Cardiology"},{"key":"1682_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/clinchem\/37.8.1405","volume":"37","author":"W Gerhardt","year":"1991","unstructured":"Gerhardt, W. et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin. Chem. 37, 1405\u20131411 (1991).","journal-title":"Clin. Chem."},{"key":"1682_CR47","doi-asserted-by":"crossref","unstructured":"Anderson, J., Seol, H., Gordish-Dressman, H., Hathout, Y., Spurney, C. F. & CINRG Investigators. Interleukin 1 Receptor-Like 1 Protein (ST2) is a potential biomarker for cardiomyopathy in Duchenne muscular dystrophy. Pediatr. Cardiol. 38, 1606\u20131612 (2017).","DOI":"10.1007\/s00246-017-1703-9"},{"key":"1682_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cardfail.2019.02.006","volume":"25","author":"JH Soslow","year":"2019","unstructured":"Soslow, J. H. et al. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Duchenne muscular dystrophy cardiomyopathy. J. Card. Fail. 25, 259\u2013267 (2019).","journal-title":"J. Card. Fail"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01682-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T13:03:59Z","timestamp":1671627839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01682-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01682-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Appropriate consents and assents were obtained as part of study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}